157 related articles for article (PubMed ID: 8417203)
1. Urodynamic effects of intravesical instillation of atropine and phentolamine in patients with detrusor hyperactivity.
Ekström B; Andersson KE; Mattiasson A
J Urol; 1993 Jan; 149(1):155-8. PubMed ID: 8417203
[TBL] [Abstract][Full Text] [Related]
2. Urodynamic effects of intravesical instillation of terodiline in healthy volunteers and in patients with detrusor hyperactivity.
Ekström B; Andersson KE; Mattiasson A
J Urol; 1992 Dec; 148(6):1840-3; discussion 1843-4. PubMed ID: 1433617
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity.
Mattiasson A; Ekström B; Andersson KE
J Urol; 1989 Jan; 141(1):174-7. PubMed ID: 2908945
[TBL] [Abstract][Full Text] [Related]
4. Intravesical instillation of drugs in patients with detrusor hyperactivity.
Ekström B
Scand J Urol Nephrol Suppl; 1992; 149():1-67. PubMed ID: 1290084
[TBL] [Abstract][Full Text] [Related]
5. Intravesical capsaicin for treatment of detrusor hyperreflexia.
Fowler CJ; Beck RO; Gerrard S; Betts CD; Fowler CG
J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):169-73. PubMed ID: 8126498
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions.
de Sèze M; Wiart L; Joseph PA; Dosque JP; Mazaux JM; Barat M
Neurourol Urodyn; 1998; 17(5):513-23. PubMed ID: 9776014
[TBL] [Abstract][Full Text] [Related]
7. Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study.
Lazzeri M; Calò G; Spinelli M; Guerrini R; Salvadori S; Beneforti P; Sandri S; Regoli D; Turini D
Urology; 2003 May; 61(5):946-50. PubMed ID: 12736013
[TBL] [Abstract][Full Text] [Related]
8. The effect of intravesical Marcain instillation on hyperreflexic detrusor contractions.
McInerney PD; Grant A; Chawla J; Stephenson TP
Paraplegia; 1992 Feb; 30(2):127-30. PubMed ID: 1589288
[TBL] [Abstract][Full Text] [Related]
9. Intravesical instillation of capsaicin in urology: A review of the literature.
de Sèze M; Wiart L; Ferrière J; de Sèze MP; Joseph P; Barat M
Eur Urol; 1999 Oct; 36(4):267-77. PubMed ID: 10473984
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
11. [Intravesical instillation of atropine in treatment of detrusor overactivity in children].
Kroll P; Jankowski A; Martyński M
Wiad Lek; 1998; 51 Suppl 3():87-91. PubMed ID: 9814113
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial.
Stöhrer M; Madersbacher H; Richter R; Wehnert J; Dreikorn K
Spinal Cord; 1999 Mar; 37(3):196-200. PubMed ID: 10213329
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions.
Kuo HC
BJU Int; 2003 Oct; 92(6):597-601. PubMed ID: 14511042
[TBL] [Abstract][Full Text] [Related]
15. [Reiterated intravesical instillation of capsaicin in neurogenic detrusor hyperreflexia: a 5-years experience of 100 instillations].
de Sèze M; Wiart L; de Sèze MP; Joseph PA; Brochet B; Ferrière JM; Mazaux JM; Barat M
Ann Readapt Med Phys; 2001 Nov; 44(8):514-24. PubMed ID: 11788114
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor.
Lazzeri M; Beneforti P; Turini D
J Urol; 1997 Dec; 158(6):2093-6. PubMed ID: 9366319
[TBL] [Abstract][Full Text] [Related]
17. Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study.
Lazzeri M; Calò G; Spinelli M; Malaguti S; Guerrini R; Salvadori S; Beneforti P; Regoli D; Turini D
J Urol; 2006 Nov; 176(5):2098-102. PubMed ID: 17070267
[TBL] [Abstract][Full Text] [Related]
18. Influence of adrenergic agonists and antagonists on urethral pressure, bladder pressure and detrusor hyperactivity in children with myelodysplasia.
Amark P; Nergårdh A
Acta Paediatr Scand; 1991; 80(8-9):824-32. PubMed ID: 1957602
[TBL] [Abstract][Full Text] [Related]
19. Influence of atropine and isoprenaline on detrusor hyperactivity in children with neurogenic bladder.
Naglo AS; Nergårdh A; Boréus LO
Scand J Urol Nephrol; 1981; 15(2):97-102. PubMed ID: 7330612
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
